Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Just a few hours left in 3Q

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Oct 01, 2024 12:49am

140 Views

Post# 36247723

RE:Just a few hours left in 3Q

Beano, if memory recalls, they did not announce pre-BTD last time they sent it to the FDA. No reason to believe they will tell us now either. If they choose to tell us, fine. But unless the powers that be has desired additional info of some kind, there is every reason to believe they will send it in now. Then, unless they get told other info/data is needed first, actual BTD- application should follow soonish imho

<< Previous

Bullboard Posts

Next >>

Understanding Implied Volatility in Options Trading